Subscribe

Receive updates about our latest products in your inbox

Register For Our Next Webinar

The Biotics Research Quality Difference

About Us

For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional

Search the Blog

    Lipoic Acid & Migraines

    iStock-1358208519The effect of alpha-lipoic acid (ALA) on women with episodic migraines was recently published in the Nature Research journal Scientific Reports. In this randomized and double-blinded trial, 92 women between the ages of 20-50 with episodic migraines (< 15 headache days per month) received either 300 mg ALA twice per day or a matching placebo for a period of 3 months. In addition to clinical symptoms, serum levels of lactate, NO (nitric oxide), and VCAM-1 (vascular cell adhesion molecule-1) were included in the analysis. 

    Among the 79 women that completed the trial, a significant reduction in headache severity and frequency was reported (but not duration), along with improvement in indices related to daily performance and well-being. For example, the ALA group had a mean reduction in headache days per month of 2.55 (a nearly 45% decrease) vs. 0.40 (7% decrease) in the control group. After multivariate adjustment, a significant decrease in serum lactate and VCAM-1 was also observed with ALA supplementation, indicating potential improvements in mitochondrial function and endothelial function, respectively. 

    This is not the first report of a potential benefit of ALA supplementation for migraineurs. A 2007 study at the same dose found a prophylactic effect of ALA, as did an uncontrolled study at 800 mg per day.

    Submit your comment

    Related Post

    Improved Quality of Life with Magnesium

    Recent research looked at the disability levels, quality of life, and anxiety and depressive symptoms in 34 children age...

    Learn more